ArticleScientific reports2026
Association between blood urea nitrogen-to-potassium ratio trajectories and MAKE-30 risk in critically patients with non-traumatic subarachnoid hemorrhage.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
This study investigates the association between short-term longitudinal blood urea nitrogen-to-potassium ratio (BPR) trajectories and the risk of major adverse kidney events within 30 days (MAKE-30) in patients with non-traumatic subarachnoid hemorrhage (n-SAH). This study used Latent Class Growth Modeling to identify BPR trajectories and applied Kaplan-Meier curves and Cox regression to assess their association with outcomes like MAKE‑30 and acute kidney injury (AKI). The research subjects included 476 patients with n-SAH, and three different BPR trajectory patterns were identified. Kaplan-Meier curves demonstrated that Class 3 patients exhibited significantly lower survival rates for MAKE-30, AKI, 30-day, 90-day, 180-day, and 365-day mortality compared to other trajectory groups (all P < 0.0001). Consistently, multivariable Cox regression analysis demonstrated that patients in Class 3 remained significantly associated with higher risks of both MAKE-30 (HR = 2.59, 95% CI: 1.03 ~ 6.48, P = 0.043) and AKI (HR = 14.43, 95% CI: 6.18 ~ 33.7, P < 0.001). This association was more pronounced in subgroups, including patients over 65, those with diabetes, and those not treated with CCB, who showed a significantly higher risk of MAKE-30 (all P < 0.01). The study suggests that persistently high BPR levels are significantly associated with an elevated risk of MAKE-30.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.